Stimuli-Responsive Nanodiamond-Based Biosensor for Enhanced Metastatic Tumor Site Detection

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cancer Biology

Background:

• Metastasis is a critical factor in cancer progression, often leading to poor patient survival and drug resistance.
• Early detection of metastasis and identification of metastatic sites are crucial for improving patient outcomes.
• Matrix metalloproteinase 9 (MMP9) is a significant biomarker for metastasis, with elevated levels indicating disease spread.

Purpose of the Study:

• To develop a novel stimuli-responsive detection complex for cancer metastasis using nanodiamonds.
• To utilize matrix metalloproteinase 9 (MMP9) as the target biomarker for metastasis detection.
• To create a nanodiamond-MMP9 biosensor for accurate measurement of MMP9 activity and expression.

Main Methods:

• Functionalization of nanodiamonds with MMP9-specific, fluorescent-labeled substrate peptides.
• Development of a nanodiamond-MMP9 biosensor complex.
• Evaluation of the biosensor's ability to measure MMP9 protease activity and correlate it with MMP9 expression.
• Assessment of the biosensor's capacity to protect sensor peptides from nonspecific serum protease cleavage.

Main Results:

• The nanodiamond-MMP9 biosensor accurately measured MMP9 protease activity, correlating with MMP9 expression.
• The biosensor demonstrated enhanced stability, protecting the substrate peptide from nonspecific cleavage in serum.
• The developed complex exhibited a quantitative, stimuli-responsive output, indicating its potential for detection.

Conclusions:

• The nanodiamond-MMP9 biosensor shows significant promise for the early detection and site identification of cancer metastasis.
• Nanodiamonds serve as a versatile platform for developing stimuli-responsive biosensors and theranostic complexes.
• This technology has broad potential applications across various biomedical fields for improved diagnostics and therapeutics.